Sanofi-Aventis Deutschland GmbH

General information
Sanofi-Aventis Deutschland GmbH
Industriepark Höchst
65926 Frankfurt, Hessen

Contact person: Anne Reuschenbach, General Manager
Company main phone: +49 (69) 30580710
Company main fax:  +49 (69) 30516883
Source of foundation:Subsidiary
Name of foundation source:Sanofi Group, France
No. of employees: Worldwide:  100000
Corporate description / mission:
Sanofi-Aventis Deutschland GmbH manufactures and markets medicines, serums, and vaccines. The company's products are used to treat diabetes, cancer, heart failures, strokes, allergies, asthma, skin diseases, multiple sclerosis, osteoporosis, and tinnitus.
Frankfurt location covers the entire value chain from research and development as well as production and manufacturing for modern biologicals, the importance of which for medical care is constantly increasing.
State of ownership: Subsidiary
Headquarters: HQ: No
Remarks on ownership / listings
Sanofi-Aventis Deutschland GmbH was formerly known as Aventis Pharma Deutschland GmbH and changed its name to Sanofi-Aventis Deutschland GmbH in September 2005.

Sanofi-Aventis Deutschland GmbH operates as a subsidiary of Sanofi.
  • Pharma (fully integrated)
  • Antibodies
  • Proteins
  • Small molecule therapeutics
  • Vaccines
Primary therapeutic areas:
  • Cardiovascular / cardiology
  • Diseases of the nervous system / neurology
  • Endocrine, nutritional and metabolic diseases / endocrinology
  • Infectious and parasitic diseases / infectiology / parasitology
  • Musculoskeletal system and connective tissue / Orthopedics
  • Neoplasms / cancer / oncology
  • Respiratory / pulmonology
  • Skin and subcutaneous tissue / dermatology
Business model:
  • Manufacturer
  • R&D
  • Subsidiary
  • Supplier / Distributor
Customer segments:
  • Hospitals
  • Large biotech & big pharma
  • Physicians / doctors
  • Small biotech
  • Direct (own sales force)
Summary Products / Services / Technologies
Description of products:
Ergenyl ®
Caprelsa ®
Aubagio ®
Lemtrada ®, etc.